Read news on crispr therapeutics with our app.
Read more in the app
Historic FDA approval of the first CRISPR-Cas9 drug for Sickle Cell Disease based on discoveries from Jennifer Doudna & Emmanuelle Charpentier, CRISPR Therapeutics & Vertex Pharmaceuticals.
